Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Apri® (desogestrel and ethinyl estradiol) Tablets
Medication labelWhy this: Advisory · dailymed-prescription
Apri (desogestrel and ethinyl estradiol) Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates. In a clinical trial with desogestrel and ethinyl estradiol tablets, 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. This represents an overall user-efficacy (typical user-efficacy) pregnancy rate of 1.12 per 100 women-years. This rate includes patients who did not take the drug correctly.
- generic_name
- desogestrel and ethinyl estradiol
- brand_name
- INERT
- product_names
- Desogestrel and Ethinyl Estradiol, INERT
- ndc
- 54868-4754, 0555-9043, 54868-4754-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en